US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% META $728.08 ▲+0.00% NVDA $233.95 ▲+0.00% TSLA $370.59 ▲+0.00% AMD $633.91 ▲+0.00% JNJ $256.03 ▲+0.00% SPCX $158.96 ▲+0.00%
FinancialContent

Articles published by Intersect ENT, Inc.

News headline image
Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
News headline image
Intersect ENT Reports Third Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
News headline image
Intersect ENT Reports Second Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
News headline image
Intersect ENT to Report Second Quarter 2021 Financial Results on August 6
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
News headline image
Intersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
News headline image
Intersect ENT Receives CE Mark Approval for PROPEL® Contour for Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
News headline image
Intersect ENT Reports First Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
News headline image
Intersect ENT to Participate at Upcoming Investor Conferences
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
News headline image
Intersect ENT Announces Appointment of New Vice President of Sales
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
News headline image
Intersect ENT Announces Date Change for First Quarter 2021 Financial Results Announcement
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
News headline image
EXPAND Post-Market Study Evaluating Longer-Term Outcomes of PROPEL® Contour Sinus Implant in the Frontal Sinus Ostia Following In-Office Balloon Sinus Dilation
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT
News headline image
Intersect ENT to Report First Quarter 2021 Financial Results
From Intersect ENT, Inc.
Via Business Wire
Tickers XENT